Recombinant CD200 (Samalizumab Biosimilar) antibody

Catalog No. ABIN7675716

The Human Monoclonal anti-CD200 (Samalizumab Biosimilar) antibody is suitable to detect CD200 (Samalizumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant CD200 (Samalizumab Biosimilar) antibody (ABIN7675716)

Target: CD200 (Samalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD200 (Samalizumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD200 (Samalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD200 Reference Antibody (samalizumab)

Characteristics: Anti-CD200 Reference Antibody (samalizumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 144.94 kDa.

Purity: >95 %

Isotype: IgG2SA

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD200 (Samalizumab Biosimilar)

Target: CD200 (Samalizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 144.94 kDa

UniProt: P41217